Association of polymorphisms of adiponectin gene promoter-11377C/G, glutathione peroxidase-1 gene C594T, and cigarette smoking in nonalcoholic fatty liver disease
Abstract Background The number of studies on adiponectin , GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have investigated the effect of cigarette smoking in combination with the gene polymorphisms on the susceptibility to NAFLD. In ord...
Saved in:
Published in | Journal of the Chinese Medical Association Vol. 79; no. 4; pp. 195 - 204 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Taiwan LLC
01.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background The number of studies on adiponectin , GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have investigated the effect of cigarette smoking in combination with the gene polymorphisms on the susceptibility to NAFLD. In order to understand the distribution of adiponectin and GPx-1 in the local population, to explore the possible association of cigarette smoking with adiponectin and GPx-1 gene polymorphisms in the pathogenesis of NAFLD, we conducted this research, examining the distribution of polymorphisms of adiponectin and GPx-1 in NAFLD patients and healthy controls, analyzing the association between these polymorphisms and cigarette smoking. Methods Two hundred nonalcoholic simple fatty liver (NAFL), 200 nonalcoholic steatohepatitis (NASH), and 200 nonalcoholic fatty hepatic cirrhosis (NAFHC) cases from the First Affiliated Hospital of Xinxiang Medical College in China from February 2011 to November 2014 were selected for this study, and 200 healthy individuals as a control group. No significant difference among the four groups in age, sex, ethnicity, and birthplace was observed. The genetic polymorphisms of adiponectin gene promoter-11377C/G and GPx-1 gene C594T were analyzed using polymerase chain reaction-restriction fragment length polymorphisms in peripheral blood leukocytes of the above-mentioned cases. The interaction between the two mutants and the gene-environment association of the genotypes with cigarette smoking were analyzed. Results The frequencies of adiponectin gene promoter-11377C/G(CG), -11377C/G (GG), GPx-1 gene C594T (CT) and C594T (TT) were 24.50%, 26.00%, 24.00%, and 25.50% in the NAFL group, 34.50%, 37.00%, 35.00%, and 36.00% in the NASH group, 42.00%, 46.00%, 43.50%, and 45.50% in the NAFHC group, and 14.00%, 14.50%, 13.00%, and 14.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group ( p < 0.01). The risk of NAFLD significantly increased in patients with adiponectin gene promoter-11377C/G (CG) genotype [odds ratio (OR)NAFL = 2.5278; ORNASH = 6.1823; ORNAFHC = 17.8570), in those with -11377C/G (GG) genotype (ORNAFL = 2.5900; ORNASH = 6.4017; ORNAFHC = 18.9023), in those with GPx-1 gene C594T (CT) genotype (ORNAFL = 2.6687; ORNASH = 6.7772; ORNAFHC = 22.2063), and in those with C594T (TT) genotype (ORNAFL = 2.6330; ORNASH = 6.4729; ORNAFHC = 21.5682). Combined analysis of the polymorphisms showed that percentages of adiponectin gene promoter -11377C/G (GG)/ GPx-1 gene C594T (TT) in the NAFL, the NASH, NAFHC, and control groups was 7.00%, 13.50%, 21.00%, and 2.00%, respectively ( p < 0.01). The people who carried the adiponectin gene promoter -11377C/G (GG)/ GPx-1 gene C594T (TT) had a high risk of NAFLD (ORNAFL = 7.2800; ORNASH = 41.2941; ORNAFHC = 363.9724), and statistical analysis suggested a positive association between -11377C/G (GG) and C594T (TT) in increasing the risk of NAFLD (γ2NAFL = 2.2071, γ4 NAFL = 2.0773; γ2 NASH = 2.1084; γ4NASH = 2.0543; γ2 NAFHC = 2.1387; γ4NAFHC = 2.0004). Likewise, there were also positive association in the pathogenesis of NAFLD between -11377C/G (CG) and C594T (TT), -11377C/G (CG) and C594T (CT), -11377C/G (GG), and C594T (TT) (CT).The frequencies of smoking index (SI) ≤ 400 and SI > 400 were 22.50% and 26.50% in the NAFL group, 29.00% and 40.50% in the NASH group, 34.00% and 51.50% in the NAFHC group, and 15.50% and 12.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (all p < 0.01). The risk of NAFLD significantly increased in patients with SI ≤ 400 (ORNAFL = 2.0636; ORNASH = 4.4474; ORNAFH C = 10.9677) and in those with SI > 400 (ORNAFL = 3.1393; ORNASH = 8.0225; ORNAFHC = 21.4583), and statistical analysis suggested a positive association between cigarette smoking and -11377C/G (CG), -11377C/G (GG), C594T (CT), and C594T (TT) in increasing the risk of NAFLD (all γ > 1). Conclusion Adiponectin gene promoter -11377C/G (CG), -11377C/G (GG), GPx-1 gene C594T (CT), C594T (TT), and cigarette smoking are risk factors in NAFLD, and the significant association between genetic polymorphisms of -11377C/G, C594T, and cigarette smoking amplify the risk of NAFLD. |
---|---|
AbstractList | BACKGROUNDThe number of studies on adiponectin, GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have investigated the effect of cigarette smoking in combination with the gene polymorphisms on the susceptibility to NAFLD. In order to understand the distribution of adiponectin and GPx-1 in the local population, to explore the possible association of cigarette smoking with adiponectin and GPx-1 gene polymorphisms in the pathogenesis of NAFLD, we conducted this research, examining the distribution of polymorphisms of adiponectin and GPx-1 in NAFLD patients and healthy controls, analyzing the association between these polymorphisms and cigarette smoking.METHODSTwo hundred nonalcoholic simple fatty liver (NAFL), 200 nonalcoholic steatohepatitis (NASH), and 200 nonalcoholic fatty hepatic cirrhosis (NAFHC) cases from the First Affiliated Hospital of Xinxiang Medical College in China from February 2011 to November 2014 were selected for this study, and 200 healthy individuals as a control group. No significant difference among the four groups in age, sex, ethnicity, and birthplace was observed. The genetic polymorphisms of adiponectin gene promoter-11377C/G and GPx-1 gene C594T were analyzed using polymerase chain reaction-restriction fragment length polymorphisms in peripheral blood leukocytes of the above-mentioned cases. The interaction between the two mutants and the gene-environment association of the genotypes with cigarette smoking were analyzed.RESULTSThe frequencies of adiponectin gene promoter-11377C/G(CG), -11377C/G (GG), GPx-1 gene C594T (CT) and C594T (TT) were 24.50%, 26.00%, 24.00%, and 25.50% in the NAFL group, 34.50%, 37.00%, 35.00%, and 36.00% in the NASH group, 42.00%, 46.00%, 43.50%, and 45.50% in the NAFHC group, and 14.00%, 14.50%, 13.00%, and 14.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (p < 0.01). The risk of NAFLD significantly increased in patients with adiponectin gene promoter-11377C/G (CG) genotype [odds ratio (OR)NAFL = 2.5278; ORNASH = 6.1823; ORNAFHC = 17.8570), in those with -11377C/G (GG) genotype (ORNAFL = 2.5900; ORNASH = 6.4017; ORNAFHC = 18.9023), in those with GPx-1 gene C594T (CT) genotype (ORNAFL = 2.6687; ORNASH = 6.7772; ORNAFHC = 22.2063), and in those with C594T (TT) genotype (ORNAFL = 2.6330; ORNASH = 6.4729; ORNAFHC = 21.5682). Combined analysis of the polymorphisms showed that percentages of adiponectin gene promoter -11377C/G (GG)/GPx-1 gene C594T (TT) in the NAFL, the NASH, NAFHC, and control groups was 7.00%, 13.50%, 21.00%, and 2.00%, respectively (p < 0.01). The people who carried the adiponectin gene promoter -11377C/G (GG)/GPx-1 gene C594T (TT) had a high risk of NAFLD (ORNAFL = 7.2800; ORNASH = 41.2941; ORNAFHC = 363.9724), and statistical analysis suggested a positive association between -11377C/G (GG) and C594T (TT) in increasing the risk of NAFLD (γ2NAFL = 2.2071, γ4 NAFL = 2.0773; γ2 NASH = 2.1084; γ4NASH = 2.0543; γ2 NAFHC = 2.1387; γ4NAFHC = 2.0004). Likewise, there were also positive association in the pathogenesis of NAFLD between -11377C/G (CG) and C594T (TT), -11377C/G (CG) and C594T (CT), -11377C/G (GG), and C594T (TT) (CT).The frequencies of smoking index (SI) ≤ 400 and SI > 400 were 22.50% and 26.50% in the NAFL group, 29.00% and 40.50% in the NASH group, 34.00% and 51.50% in the NAFHC group, and 15.50% and 12.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (all p < 0.01). The risk of NAFLD significantly increased in patients with SI ≤ 400 (ORNAFL = 2.0636; ORNASH = 4.4474; ORNAFH C = 10.9677) and in those with SI > 400 (ORNAFL = 3.1393; ORNASH = 8.0225; ORNAFHC = 21.4583), and statistical analysis suggested a positive association between cigarette smoking and -11377C/G (CG), -11377C/G (GG), C594T (CT), and C594T (TT) in increasing the risk of NAFLD (all γ > 1).CONCLUSIONAdiponectin gene promoter -11377C/G (CG), -11377C/G (GG), GPx-1 gene C594T (CT), C594T (TT), and cigarette smoking are risk factors in NAFLD, and the significant association between genetic polymorphisms of -11377C/G, C594T, and cigarette smoking amplify the risk of NAFLD. Abstract Background The number of studies on adiponectin , GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have investigated the effect of cigarette smoking in combination with the gene polymorphisms on the susceptibility to NAFLD. In order to understand the distribution of adiponectin and GPx-1 in the local population, to explore the possible association of cigarette smoking with adiponectin and GPx-1 gene polymorphisms in the pathogenesis of NAFLD, we conducted this research, examining the distribution of polymorphisms of adiponectin and GPx-1 in NAFLD patients and healthy controls, analyzing the association between these polymorphisms and cigarette smoking. Methods Two hundred nonalcoholic simple fatty liver (NAFL), 200 nonalcoholic steatohepatitis (NASH), and 200 nonalcoholic fatty hepatic cirrhosis (NAFHC) cases from the First Affiliated Hospital of Xinxiang Medical College in China from February 2011 to November 2014 were selected for this study, and 200 healthy individuals as a control group. No significant difference among the four groups in age, sex, ethnicity, and birthplace was observed. The genetic polymorphisms of adiponectin gene promoter-11377C/G and GPx-1 gene C594T were analyzed using polymerase chain reaction-restriction fragment length polymorphisms in peripheral blood leukocytes of the above-mentioned cases. The interaction between the two mutants and the gene-environment association of the genotypes with cigarette smoking were analyzed. Results The frequencies of adiponectin gene promoter-11377C/G(CG), -11377C/G (GG), GPx-1 gene C594T (CT) and C594T (TT) were 24.50%, 26.00%, 24.00%, and 25.50% in the NAFL group, 34.50%, 37.00%, 35.00%, and 36.00% in the NASH group, 42.00%, 46.00%, 43.50%, and 45.50% in the NAFHC group, and 14.00%, 14.50%, 13.00%, and 14.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group ( p < 0.01). The risk of NAFLD significantly increased in patients with adiponectin gene promoter-11377C/G (CG) genotype [odds ratio (OR)NAFL = 2.5278; ORNASH = 6.1823; ORNAFHC = 17.8570), in those with -11377C/G (GG) genotype (ORNAFL = 2.5900; ORNASH = 6.4017; ORNAFHC = 18.9023), in those with GPx-1 gene C594T (CT) genotype (ORNAFL = 2.6687; ORNASH = 6.7772; ORNAFHC = 22.2063), and in those with C594T (TT) genotype (ORNAFL = 2.6330; ORNASH = 6.4729; ORNAFHC = 21.5682). Combined analysis of the polymorphisms showed that percentages of adiponectin gene promoter -11377C/G (GG)/ GPx-1 gene C594T (TT) in the NAFL, the NASH, NAFHC, and control groups was 7.00%, 13.50%, 21.00%, and 2.00%, respectively ( p < 0.01). The people who carried the adiponectin gene promoter -11377C/G (GG)/ GPx-1 gene C594T (TT) had a high risk of NAFLD (ORNAFL = 7.2800; ORNASH = 41.2941; ORNAFHC = 363.9724), and statistical analysis suggested a positive association between -11377C/G (GG) and C594T (TT) in increasing the risk of NAFLD (γ2NAFL = 2.2071, γ4 NAFL = 2.0773; γ2 NASH = 2.1084; γ4NASH = 2.0543; γ2 NAFHC = 2.1387; γ4NAFHC = 2.0004). Likewise, there were also positive association in the pathogenesis of NAFLD between -11377C/G (CG) and C594T (TT), -11377C/G (CG) and C594T (CT), -11377C/G (GG), and C594T (TT) (CT).The frequencies of smoking index (SI) ≤ 400 and SI > 400 were 22.50% and 26.50% in the NAFL group, 29.00% and 40.50% in the NASH group, 34.00% and 51.50% in the NAFHC group, and 15.50% and 12.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (all p < 0.01). The risk of NAFLD significantly increased in patients with SI ≤ 400 (ORNAFL = 2.0636; ORNASH = 4.4474; ORNAFH C = 10.9677) and in those with SI > 400 (ORNAFL = 3.1393; ORNASH = 8.0225; ORNAFHC = 21.4583), and statistical analysis suggested a positive association between cigarette smoking and -11377C/G (CG), -11377C/G (GG), C594T (CT), and C594T (TT) in increasing the risk of NAFLD (all γ > 1). Conclusion Adiponectin gene promoter -11377C/G (CG), -11377C/G (GG), GPx-1 gene C594T (CT), C594T (TT), and cigarette smoking are risk factors in NAFLD, and the significant association between genetic polymorphisms of -11377C/G, C594T, and cigarette smoking amplify the risk of NAFLD. The number of studies on adiponectin, GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have investigated the effect of cigarette smoking in combination with the gene polymorphisms on the susceptibility to NAFLD. In order to understand the distribution of adiponectin and GPx-1 in the local population, to explore the possible association of cigarette smoking with adiponectin and GPx-1 gene polymorphisms in the pathogenesis of NAFLD, we conducted this research, examining the distribution of polymorphisms of adiponectin and GPx-1 in NAFLD patients and healthy controls, analyzing the association between these polymorphisms and cigarette smoking. Two hundred nonalcoholic simple fatty liver (NAFL), 200 nonalcoholic steatohepatitis (NASH), and 200 nonalcoholic fatty hepatic cirrhosis (NAFHC) cases from the First Affiliated Hospital of Xinxiang Medical College in China from February 2011 to November 2014 were selected for this study, and 200 healthy individuals as a control group. No significant difference among the four groups in age, sex, ethnicity, and birthplace was observed. The genetic polymorphisms of adiponectin gene promoter-11377C/G and GPx-1 gene C594T were analyzed using polymerase chain reaction-restriction fragment length polymorphisms in peripheral blood leukocytes of the above-mentioned cases. The interaction between the two mutants and the gene-environment association of the genotypes with cigarette smoking were analyzed. The frequencies of adiponectin gene promoter-11377C/G(CG), -11377C/G (GG), GPx-1 gene C594T (CT) and C594T (TT) were 24.50%, 26.00%, 24.00%, and 25.50% in the NAFL group, 34.50%, 37.00%, 35.00%, and 36.00% in the NASH group, 42.00%, 46.00%, 43.50%, and 45.50% in the NAFHC group, and 14.00%, 14.50%, 13.00%, and 14.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (p < 0.01). The risk of NAFLD significantly increased in patients with adiponectin gene promoter-11377C/G (CG) genotype [odds ratio (OR)NAFL = 2.5278; ORNASH = 6.1823; ORNAFHC = 17.8570), in those with -11377C/G (GG) genotype (ORNAFL = 2.5900; ORNASH = 6.4017; ORNAFHC = 18.9023), in those with GPx-1 gene C594T (CT) genotype (ORNAFL = 2.6687; ORNASH = 6.7772; ORNAFHC = 22.2063), and in those with C594T (TT) genotype (ORNAFL = 2.6330; ORNASH = 6.4729; ORNAFHC = 21.5682). Combined analysis of the polymorphisms showed that percentages of adiponectin gene promoter -11377C/G (GG)/GPx-1 gene C594T (TT) in the NAFL, the NASH, NAFHC, and control groups was 7.00%, 13.50%, 21.00%, and 2.00%, respectively (p < 0.01). The people who carried the adiponectin gene promoter -11377C/G (GG)/GPx-1 gene C594T (TT) had a high risk of NAFLD (ORNAFL = 7.2800; ORNASH = 41.2941; ORNAFHC = 363.9724), and statistical analysis suggested a positive association between -11377C/G (GG) and C594T (TT) in increasing the risk of NAFLD (γ2NAFL = 2.2071, γ4 NAFL = 2.0773; γ2 NASH = 2.1084; γ4NASH = 2.0543; γ2 NAFHC = 2.1387; γ4NAFHC = 2.0004). Likewise, there were also positive association in the pathogenesis of NAFLD between -11377C/G (CG) and C594T (TT), -11377C/G (CG) and C594T (CT), -11377C/G (GG), and C594T (TT) (CT).The frequencies of smoking index (SI) ≤ 400 and SI > 400 were 22.50% and 26.50% in the NAFL group, 29.00% and 40.50% in the NASH group, 34.00% and 51.50% in the NAFHC group, and 15.50% and 12.00% in the control group, respectively. Statistical tests showed a significant difference in the frequencies among each group (all p < 0.01). The risk of NAFLD significantly increased in patients with SI ≤ 400 (ORNAFL = 2.0636; ORNASH = 4.4474; ORNAFH C = 10.9677) and in those with SI > 400 (ORNAFL = 3.1393; ORNASH = 8.0225; ORNAFHC = 21.4583), and statistical analysis suggested a positive association between cigarette smoking and -11377C/G (CG), -11377C/G (GG), C594T (CT), and C594T (TT) in increasing the risk of NAFLD (all γ > 1). Adiponectin gene promoter -11377C/G (CG), -11377C/G (GG), GPx-1 gene C594T (CT), C594T (TT), and cigarette smoking are risk factors in NAFLD, and the significant association between genetic polymorphisms of -11377C/G, C594T, and cigarette smoking amplify the risk of NAFLD. |
Author | Guo, Li-Ke Li, Guang-Yan Qin, Yong-Mei Zhang, Chao-Xian |
Author_xml | – sequence: 1 fullname: Zhang, Chao-Xian – sequence: 2 fullname: Guo, Li-Ke – sequence: 3 fullname: Qin, Yong-Mei – sequence: 4 fullname: Li, Guang-Yan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26897098$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAYhSNURC_wAiyQlyya1HZ8iSWEVI2grVSJBWVtOc6fGU-TONhOxbwOT4rDFBYs8MaWfc6xjj-fFyeTn6Ao3hJcEUzE1b7a29FUFBNeYVVhXL8ozoikTSllTU5-r0XJFCanxXmMe4yZUIq_Kk6paJTEqjkrfl7H6K0zyfkJ-R7NfjiMPsw7F8e4bpjOzflam9yEtjABmoMffYJQElJLubm6uUTbYUkm7XJEPobgf7jORCjJ0bDhij1cIjN1yLqtCZASoDj6RzdtUU7Nrcxg_c4PzqLepHRAg3uCgDoXIee8Ll72Zojw5nm-KL59_vSwuS3vv9zcba7vS8s4T6WosRAKegZd2-AWs9qyhshetLzGTUcMb3tDiWjbRmLWUAoKKBOCcMVrxfr6onh_zM0Nvy8Qkx5dtDAMZgK_RE2kVE0juZBZSo9SG3yMAXo9BzeacNAE65WN3uuVjV7ZaKx0ZpNN757zl3aE7q_lD4ws-HAUQG755CDoaB1MFjoXMgDdeff__I__2O3gJmfN8AgHiHu_hPzQuYeOVGP9df0d6-cgAudBaf0Lj_a3cQ |
CitedBy_id | crossref_primary_10_1007_s11356_022_21090_4 crossref_primary_10_1155_2021_5594505 crossref_primary_10_1002_iub_2302 crossref_primary_10_3389_fendo_2022_798417 crossref_primary_10_1002_mgg3_824 crossref_primary_10_1097_JCMA_0000000000000437 crossref_primary_10_1002_mgg3_624 crossref_primary_10_1016_j_jep_2020_112729 crossref_primary_10_3390_nu15132880 crossref_primary_10_1016_j_toxrep_2018_09_003 crossref_primary_10_1177_2050312117745223 |
ContentType | Journal Article |
Copyright | 2016 Copyright © 2016. Published by Elsevier Taiwan LLC. |
Copyright_xml | – notice: 2016 – notice: Copyright © 2016. Published by Elsevier Taiwan LLC. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.jcma.2015.09.003 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1728-7731 |
EndPage | 204 |
ExternalDocumentID | 10_1016_j_jcma_2015_09_003 26897098 S1726490116000022 1_s2_0_S1726490116000022 |
Genre | Journal Article |
GroupedDBID | --- --K .1- .FO .~1 0R~ 0SF 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5VS 6I. 7-5 71M 8P~ AAAAV AACTN AAEDW AAFTH AAHPQ AAIKJ AAIQE AALRI AAQFI AASCR AAXUO ABASU ABBQC ABDIG ABMAC ABVCZ ABVKL ABXDB ACGFS ACILI ACXJB ADBBV ADGGA ADHPY ADMUD ADPDF ADVLN AEKER AENEX AEVXI AEXQZ AFCTW AFDTB AFRHN AFTJW AGHFR AGYEJ AHQNM AHVBC AINUH AITUG AJIOK AJNWD AJRQY AJUYK AJZMW AKRWK ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ AOHHW BAWUL CS3 DIK DIWNM DU5 E3Z EBS EEVPB EJD EO8 EO9 EP2 EP3 F5P FCALG FDB FEDTE FIRID FNPLU GBLVA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HVGLF HZ~ IHE IKREB IPNFZ J1W M41 MO0 N9A NCXOZ O-L O9- OK1 OPUJH OVD OVDNE OVEED OZT P-8 P-9 P2P PC. Q38 RIG RLZ ROL RPZ RUJ SDF SDG SEL SES SSZ TEORI TR2 TSPGW TWZ Z5R LCYCR CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c455t-630669ef4edb80b043c4817f6b5308d1a5bfa216bb8704822e9e24661595394f3 |
IEDL.DBID | .~1 |
ISSN | 1726-4901 |
IngestDate | Fri Aug 16 08:41:19 EDT 2024 Fri Aug 23 02:10:07 EDT 2024 Tue Aug 27 13:44:49 EDT 2024 Fri Feb 23 02:29:41 EST 2024 Tue Oct 15 22:53:58 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | cigarette smoking glutathione peroxidase-1 gene C594T nonalcoholic fatty liver disease polymorphism adiponectin gene promoter -11377C/G |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2016. Published by Elsevier Taiwan LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c455t-630669ef4edb80b043c4817f6b5308d1a5bfa216bb8704822e9e24661595394f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9616-5795 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1726490116000022 |
PMID | 26897098 |
PQID | 1779887567 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1779887567 crossref_primary_10_1016_j_jcma_2015_09_003 pubmed_primary_26897098 elsevier_sciencedirect_doi_10_1016_j_jcma_2015_09_003 elsevier_clinicalkeyesjournals_1_s2_0_S1726490116000022 |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of the Chinese Medical Association |
PublicationTitleAlternate | J Chin Med Assoc |
PublicationYear | 2016 |
Publisher | Elsevier Taiwan LLC |
Publisher_xml | – name: Elsevier Taiwan LLC |
References | Buechler, Wanninger, Neumeier (bib10) 2011; 17 Lim, Mietus-Snyder, Valente, Schwarz, Lustig (bib2) 2010; 7 Liu, Dai, Bi, Xu, Xu, Li (bib3) 2013; 23 Jia (bib18) 2013; 26 Cao, Mu, Jiang, Yang, Chen, Xue (bib15) 2014; 35 Erdem, Eken, Akay, Arsova-Sarafinovska, Matevska, Suturkova (bib17) 2012; 31 Suzen, Gucyener, Sakalli, Uckun, Kose, Ustel (bib8) 2010; 37 Lubos, Loscalzo, Handy (bib14) 2011; 15 Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association (bib6) 2010; 26 Yalcinkaya, Celik, Gursoy (bib19) 2014; 8 Bik, Ostrowski, Baranowska-Bik, Wolinska-Witort, Bialkowska, Martynska (bib12) 2010; 31 Boyraz, Cekmez, Karaoglu, Cinaz, Durak, Bideci (bib4) 2013; 7 Gupta, Misra, Sakhuja, Singh, Basir, Sarin (bib7) 2012; 496 Nomura, Yamanouchi (bib1) 2012; 23 Zhang, Ma, Brismar, Efendic, Gu (bib13) 2009; 23 Paz-y-Miño, Muñoz, López-Cortés, Cabrera, Palacios, Castro (bib16) 2010; 18 Wallace (bib9) 2006; 3 Wang, Zhang, Chen, Liu, Lan, Chen (bib11) 2009; 84 Samy, Hassanian (bib5) 2011; 12 |
References_xml | – volume: 18 start-page: 395 year: 2010 end-page: 400 ident: bib16 article-title: Frequency of polymorphisms pro198leu in publication-title: Oncol Res contributor: fullname: Castro – volume: 15 start-page: 1957 year: 2011 end-page: 1997 ident: bib14 article-title: Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities publication-title: Antioxid Redox Signal contributor: fullname: Handy – volume: 31 start-page: 24 year: 2012 end-page: 31 ident: bib17 article-title: Association of publication-title: Hum Exp Toxicol contributor: fullname: Suturkova – volume: 7 start-page: 737 year: 2013 end-page: 745 ident: bib4 article-title: Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease publication-title: Biomark Med contributor: fullname: Bideci – volume: 31 start-page: 497 year: 2010 end-page: 506 ident: bib12 article-title: Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women publication-title: Neuro Endocrinol Lett contributor: fullname: Martynska – volume: 37 start-page: 87 year: 2010 end-page: 92 ident: bib8 article-title: CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population publication-title: Mol Biol Rep contributor: fullname: Ustel – volume: 7 start-page: 251 year: 2010 end-page: 264 ident: bib2 article-title: The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome publication-title: Nat Rev Gastroenterol Hepatol contributor: fullname: Lustig – volume: 35 start-page: 759 year: 2014 end-page: 764 ident: bib15 article-title: Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis publication-title: Tumour Biol contributor: fullname: Xue – volume: 8 start-page: 760 year: 2014 ident: bib19 article-title: Determining the combined effects of smoking and obesity on insulin resistance and inflammation publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Gursoy – volume: 84 start-page: 205 year: 2009 end-page: 210 ident: bib11 article-title: gene variants -11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes publication-title: Diabetes Res Clin Pract contributor: fullname: Chen – volume: 26 start-page: 120 year: 2010 end-page: 124 ident: bib6 article-title: Guidelines for diagnosis and treatment of nonalcoholic fatty liver disease publication-title: J Clin Hepatol contributor: fullname: Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association – volume: 12 start-page: 80 year: 2011 end-page: 85 ident: bib5 article-title: Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin publication-title: Arab J Gastroenterol contributor: fullname: Hassanian – volume: 23 start-page: 115 year: 2013 end-page: 121 ident: bib3 article-title: Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China publication-title: J Epidemiol contributor: fullname: Li – volume: 26 start-page: 947 year: 2013 end-page: 952 ident: bib18 article-title: The impact of cigarette smoking on metabolic syndrome publication-title: Biomed Environ Sci contributor: fullname: Jia – volume: 496 start-page: 63 year: 2012 end-page: 67 ident: bib7 article-title: Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease publication-title: Gene contributor: fullname: Sarin – volume: 17 start-page: 2801 year: 2011 end-page: 2811 ident: bib10 article-title: Adiponectin, a key adipokine in obesity related liver diseases publication-title: World J Gastroenterol contributor: fullname: Neumeier – volume: 3 start-page: 35 year: 2006 ident: bib9 article-title: A model of gene–gene and gene–environment interactions and its implications for targeting environmental interventions by genotype publication-title: Theor Biol Med Model contributor: fullname: Wallace – volume: 23 start-page: 265 year: 2009 end-page: 272 ident: bib13 article-title: A single nucleotide polymorphism alters the sequence of SP1binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study publication-title: J Diabetes Complications contributor: fullname: Gu – volume: 23 start-page: 203 year: 2012 end-page: 208 ident: bib1 article-title: The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease publication-title: J Nutr Biochem contributor: fullname: Yamanouchi |
SSID | ssj0046995 |
Score | 2.1762304 |
Snippet | Abstract Background The number of studies on adiponectin , GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing,... The number of studies on adiponectin, GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none have... BACKGROUNDThe number of studies on adiponectin, GPx-1 gene polymorphisms, and nonalcoholic fatty liver disease (NAFLD) susceptibility is increasing, but none... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 195 |
SubjectTerms | Adiponectin - genetics adiponectin gene promoter -11377C/G Adolescent Adult Aged cigarette smoking Female Glutathione Peroxidase - genetics glutathione peroxidase-1 gene C594T Humans Internal Medicine Male Middle Aged Non-alcoholic Fatty Liver Disease - etiology Non-alcoholic Fatty Liver Disease - genetics nonalcoholic fatty liver disease polymorphism Polymorphism, Genetic Promoter Regions, Genetic Smoking - adverse effects |
Title | Association of polymorphisms of adiponectin gene promoter-11377C/G, glutathione peroxidase-1 gene C594T, and cigarette smoking in nonalcoholic fatty liver disease |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1726490116000022 https://dx.doi.org/10.1016/j.jcma.2015.09.003 https://www.ncbi.nlm.nih.gov/pubmed/26897098 https://search.proquest.com/docview/1779887567 |
Volume | 79 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3JbtUw0KqKhLggdh5LZSRuNDw73uJjeaJUQMuBFj1xsezErlK1SdSkElz4GL6UsZM8gSo4cIri2J5kPJ4lngWhl4JQywIhmaVcZTwPInMVGCsqQH9XMeFcDHA-PJIHJ_z9Wqy30GqOhYlulRPvH3l64tZTy3LC5rKr6-VnEL2Sx8hJSVIalxjBDsIIaPr1j42bB1h_qfJK7JzF3lPgzOjjdVam3ENUpFync-Gs68Lpb8pnEkL7d9DtSXvEe-ML3kVbvrmHbh5O5-P30c_fsI3bgLv2HGx7QGXdX_SxwVZ11zaRyTUYSMfjLrnj-Rj4xpRaLd_t4lMgxuiT2MbH_rL9Vlcg6jI6DlgJzY93sW0qXNapRu7gcX_Rxl_uGGZtomqfyu7WJQ52GL7j8-j7gaejoAfoZP_t8eogm6owZCUXYsgkGBVS-8B95QriCGclL6gK0glGiopa4YLNqXQOtj4HfcNrn3MQ-0ILpnlgD9E2gPaPEYaZCmWFVYxX3FHqmGYsKF5SJ4T0eoFezeg33Zhsw8xeaGcmLpaJi2WIjilNF0jNK2TmMFJgfL6fdmFvqOlzQ8w1SlkgsRn5B7EZkCP_hPhiJgQDuzAerdjGt1cAScW8b0pItUCPRgrZfEEuC62ILp78J9Sn6BbcydFd6BnaHi6v_HPQhAa3k0h9B93Ye_Plw0e4Hq3Wn77-AqphCME |
link.rule.ids | 315,786,790,4521,27600,27955,27956,45618,45696 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLZKKwGXip0pm5G40WjseIuPZUQZ6EwvTFFvVpzYVao2iZpUgr_DL-U5cSpQBQeu8ZY8f35L_BaE3glCc-YJSXLKVcJTLxJbgrGiPPS3JRPWhgDn9bFcnvAvp-J0Cy2mWJjgVhl5_8jTB24dn8wjNedtVc2_guiVPEROSjKkcbmDdkAb0ADznYMP345WE0MGA3AovhL6J2FAjJ0Z3bzOiyH9EBVDutOpdtZt-fQ3_XOQQ4cP0G5UIPHB-I4P0ZarH6G763hF_hj9_I3guPG4bS7AvAdqVt1lFx7kZdU2deBzNQb0ONwOHnkuxL4xpRbzT_v4DPAY3BKb0Oyumu9VCdIuoeOAhdB8s4_zusRFNZTJ7R3uLpvw1x3DrHXQ7ofKu1WBfd73P_BFcP_A8TboCTo5_LhZLJNYiCEpuBB9IsGukNp57kqbEUs4K3hGlZdWMJKVNBfW5ymV1sLp56ByOO1SDpJfaME09-wp2oal3XOEYaZM5SJXjJfcUmqZZswrXlArhHR6ht5P5DftmG_DTI5o5yZslgmbZYgOWU1nSE07ZKZIUuB9rosHsTPUdKkh5hZYZkjcjPwDbwZEyT9XfDsBwcBBDLcree2aa1hJhdRvSkg1Q89GhNx8QSozrYjO9v5z1Tfo3nKzXpnV5-OjF-g-tMjRe-gl2u6vrt0rUIx6-zoC_xej9wnQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+polymorphisms+of+adiponectin+gene+promoter-11377C%2FG%2C+glutathione+peroxidase-1+gene+C594T%2C+and+cigarette+smoking+in+nonalcoholic+fatty+liver+disease&rft.jtitle=Journal+of+the+Chinese+Medical+Association&rft.au=Zhang%2C+Chao-Xian&rft.au=Guo%2C+Li-Ke&rft.au=Qin%2C+Yong-Mei&rft.au=Li%2C+Guang-Yan&rft.date=2016-04-01&rft.eissn=1728-7731&rft.volume=79&rft.issue=4&rft.spage=195&rft.epage=204&rft_id=info:doi/10.1016%2Fj.jcma.2015.09.003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1726-4901&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1726-4901&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1726-4901&client=summon |